These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7111756)

  • 1. Natural history of chronic type B hepatitis.
    Hoofnagle JH; Seeff LB
    Prog Liver Dis; 1982; 7():469-79. PubMed ID: 7111756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppression of hepatitis delta virus by concurrent hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.
    Liaw YF; Hsieh SY; Chien RN; Chen TJ; Sheen IS; Chu CM
    Prog Clin Biol Res; 1993; 382():229-34. PubMed ID: 8502686
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
    Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1446-9. PubMed ID: 7680158
    [No Abstract]   [Full Text] [Related]  

  • 5. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disappearance of hepatitis B surface antigen in chronic type B hepatitis after clinical and laboratorial relapse produced by abrupt withdrawal of immunosuppressive drugs.
    da Silva LC; Mattar E; Carrilho FJ; Takeda A; Sette Júnior H; Gayotto LC
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):270-4. PubMed ID: 6608779
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experience with corticosteroid therapy of acute B type viral hepatitis].
    Matkovics A; Hollós I; Darvas G
    Orv Hetil; 1974 Jul; 115(28):1649-52. PubMed ID: 4841560
    [No Abstract]   [Full Text] [Related]  

  • 8. [A follow-up study on 103 HBsAg carriers during 16-21 years].
    Hong DQ; Li JS; Dai HM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1994 Sep; 28(5):287-90. PubMed ID: 7842894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 10. Infection with the delta agent in chronic HBsAg carriers.
    Smedile A; Dentico P; Zanetti A; Sagnelli E; Nordenfelt E; Actis GC; Rizzetto M
    Gastroenterology; 1981 Dec; 81(6):992-7. PubMed ID: 7286594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-HBc titers and anti-HBc immunoglobulin (M/G) classes in acute, chronic and resolved hepatitis B.
    Niermeijer P; Gips CH; Huizenga JR; Houthoff HJ; Snijder JA
    Hepatogastroenterology; 1980 Aug; 27(4):271-6. PubMed ID: 7203363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B in families of patients with chronic hepatitis and long-term HBs antigenemia].
    Jasiel M; Zielińska W; Tołwińska I; Chrostowska H; Weyna L
    Pol Tyg Lek; 1981 Jun; 36(22):781-4. PubMed ID: 7279758
    [No Abstract]   [Full Text] [Related]  

  • 13. Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece.
    Gigi E; Lalla T; Orphanou E; Sinakos E; Vrettou E; Raptopoulou-Gigi M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):19-22. PubMed ID: 17410284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM; Hung SJ; Lin J; Tai DI; Liaw YF
    Am J Med; 2004 Jun; 116(12):829-34. PubMed ID: 15178498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the chronic hepatitis B carrier.
    Smith BC; Watson KJ
    Aust Fam Physician; 1995 Mar; 24(3):331-9. PubMed ID: 7717895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan.
    Yang YJ; Liu CC; Chen TJ; Lee MF; Chen SH; Shih HH; Chang MH
    Pediatr Infect Dis J; 2003 Jul; 22(7):584-8. PubMed ID: 12867831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
    Lu P; Wang J; Wu Y
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
    Fedorchenko SV; Vovk AD; Rybalko SL
    Ter Arkh; 1994; 66(2):24-9. PubMed ID: 8160138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.